Summary.-Immunofluorescence studies of sera from mice with induced enhancement of tumour growth demonstrated that these sera contained factors ("interfering factors") which in an apparently competitive manner interfered with the subsequent binding of specific antibodies to antigenic sites on the tumour-cell membrane. The factors were tumour-specific but lacked some of the immunoglobulin determinants. They could not be detected by polyvalent FITC-antimouse y-globulin. Interfering factors did not seem to be related to IgA or IgE. They were demonstrable in sera from tumour -free animals without growing tumours, thus differing from the tumourspecific "blocking factors".
factors did not seem to be related to IgA or IgE. They were demonstrable in sera from tumour -free animals without growing tumours, thus differing from the tumourspecific "blocking factors". THE MECHANISM of immunological tumour enhancement has frequently been discussed (Kaliss, 1970; Snell, 1970; Winn, 1970) . Several mechanisms which contribute to the escape of antigenic tumours from immunological control have been described. Specific blocking factors which prevent immune lymphocytes from killing tumour cells represent one of the more extensively studied immunologically specific escape mechanisms (Hellstrom et al., 1977 , Baldwin & Price, 1976 . Antibodies (Hellstrom et al., 1977) antigen -antibody complexes (Sjogren et al., 1971; Baldwin et al., 1972) and tumour antigens (Currie & Basham, 1972; Thompson et al., 1973) may turn off the immune response to tumour antigen in a specific way.
In a previous publication, Laursen and Laursen (1978) have described enhanced growth of tumour grafts after two prior intracaecal inoculations of either frozen-thawed C3H mouse ascites tumour cells or live C3H mammary tumour cells. The induced enhancement was transferable to untreated animals by serum and by spleen cells.
In the present work the tumourspecific activity of sera from intracaecally immunized C3H mice was studied by the indirect membrane immunofluorescence technique. It was found that sera obtained from immunized animals, which on subsequent s.c. or i.p. tumour challenge showed either protection or enhancement, reacted antagonistically.
MATERIALS AND METHODS
Eight-to 10-week-old inbred mice of the C3H Fib strain were used for this wvork. Most of the animals were kept under conventional conditions and maintained on a standard pellet diet and water ad libitum. The animals for the experiments in Tables IV and V , however, were raised under specific-pathogen-free (SPF) conditions and kept under minimal disease conditions during the experiment.
The C3H-LI/a ascites tumour was established from cultures of C3H mouse lung fibroblasts which had undergone spontaneous malignant transformation during propagation in vitro (Kieler et al., 1972 The preparation of single-cell suspension fIrom t,he mammnary tumour and the procedure for immunization by the intracaecal (i.c.) route have been described elsewhere (Laursen & Laursen, 1978 The fluotescent index wNas calculated as (a-b)/a, where a = the percentage of fluor escent-negative cells treated with normal control serum, and b = the percentage of fluorescent-negative cells treated w,Nith the seirum to be tested (Klein & Klein, 1964) .
In order to ascertain the immune status of the serum donors a secondary challeinge with live tumour cells NN-as given by i.p. injection. The percentage of takes and the survival time N-ere recorded.
The relative contents of IgA, IgG anid 1gM in sera from mice raised under conventional and SPF conditions respectively Nere compared by rocket immunoelectrophoresis as described by Axelsen et al. (1973) .
Briefly, 1-mm-thick agarose gel containingy 75 ,ul antimouse immunoglobulins per 10 rnl gel was used. The specific antimouse immunoglobulins were produced in goats and obtained from Meloy Laboratory, Virginia, U.S.A. Eleetrophoresis was carried out at 8 V/cm in the gel for 2 h. Test A: the C3H-L1 ascites cells were incubated in the absorbed serum, washed and stained with FITC-yglobulin.
RESULTS
Test B: the target cells were subjected to a second incubation in a positive-control serum before staining with the FITC-globulin.
washing twice in PBS before incubation with the positive sera, considerably and specifically reduced the reaction of target cells with the latter. The enhancing sera raised against C3H-LI/a cells and MTC did not cross-react. Table III shows the results of an immunofluorescence test with enhancing serum, which before testing was absorbed with C3H-L1/a or STABAL-2 ascites tumour cells. As can be seen, absorption with C3H-L1/a specifically increased the immunofluorescent index after single incubation in enhancing serum, and double incubation in enhancing serum and positive control serum. Absorption with STA-BAL-2 had no such effect.
All experiments reported above were carried out with conventionally housed C3H mice. However, different results were obtained with mice raised under specific-pathogen-free (SPF) conditions. These mice are of the same strain as our conventionally housed C3H mice. Laursen & Laursen (1978) .
Several studies suggest that enhancement could be mediated by specific antibodies (Kaliss, 1958; Winn, 1970; Snell, 1970; Takasugi & Hildemann, 1969; Ran & Witz, 1972) .
In the present, immunofluorescence studies, specific antibodies could not be demonstrated in sera from mice with enhanced tumour growth, unless these sera were diluted or subjected to partial specific absorption.
However, the data presented in the  Figure and Tables II and III suggest the presence in enhancing serum of factors able to interfere with the subse-quent binding of tumour-specific antibodies in the positive-control serum to the membrane of the appropriate tumour cells. It is conceivable that these factors had covered the antigenic sites on the tumour-cell membrane. They were specifically absorbed by the immunizing tumour cells, but they lacked determinants detectable by polyvalent FITCconjugated goat anti-mouise gammaglobulin.
C3H-L1/a cells treated with a 1:4 dilution of the positive-control serum after preincubation with enhancing serum at a dilution of 1:2 showed a somewhat higher fluorescent index than cells treated with enhancing serum alone (Figure) . This indicates, either that not all antigenic sites were covered by factors in the enhancing serum, or that the interfering factors can be replaced by competing specific antibodies.
The interfering phenomenon has only been detectable when using serum from animals in which intestinal immunization was followed by enhanced growth of the challenging tumour. No interfering factors were detectable in serum from experiments in which inhibition of tumour growth followed the intestinal immunization.
These observations indicate that enhancing serum contains factors with specificity and affinity for tumour-associated antigens, but that compared with the positive-control serum these factors lack certain immunoglobulin determinants.
It has been shown that blocking sera facilitated tumour growth (Takasugi & Klein, 1971; Bansal et al., 1972) and prevented immune lymphocytes from killing tumour cells in cytotoxicity assays. But blocking factors were only detectable in sera from individuals bearing tumours; they disappeared rapidly after tumour excision (Sjogren and Baldwin et al., 1973) .
The factors presented in this paper could only be demonstrated in sera from animals in which intestinal immunization was followed by enhanced tumour growth. (Vaerman et al., 1973; Bazin et al., 1970) , equal serum IgA levels would indicate that the numbers of IgA-producing immunocytes in the intestinal wall of SPF mice are comparable to the numbers in conventional C3H mice. Because interfering factors were undetectable in serum from SPF mice, however, IgA is unlikely to have acted in such a manner. Mota (1967) reported that incubation for 30 min at 56 C destroyed the passive cutaneous anaphylactic activity of mouse IgE. Such heating of enhancing serum did not decrease its interfering capacity.
Elucidation of the nature of the interfering factors in enhancing serum requires further investigation. Future experiments should clarify whether these factors provide a mechanism whereby the antigenic tumours can escape immunological destruction. Such studies might provide information of basic importance to the understanding of immune reactions.
